Scientific work

Prof. Dr. Özlem Ercelep

90 publications. The source of the information is stated next to each publication.

Back to profile

  1. Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100668 PMID 33127167 11 citations (OpenAlex) Source: OpenAlex

  2. Does insulin resistance predict complete response in breast cancer patients who underwent neoadjuvant treatment?

    Cancer Research, 2020

    DOI 10.1158/1538-7445.sabcs19-p2-16-18 Source: ORCID

  3. Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

    World Journal of Surgical Oncology, 2020

    DOI 10.1186/s12957-020-02019-y PMID 32907593 25 citations (Europe PMC) Open-access full textSource: ORCID

  4. Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment

    Clinical Neurology and Neurosurgery, 2020

    DOI 10.1016/j.clineuro.2020.105976 PMID 32531614 6 citations (OpenAlex) Source: OpenAlex

  5. Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

    International Journal of Clinical Oncology, 2020

    DOI 10.1007/s10147-020-01767-x PMID 32797321 3 citations (OpenAlex) Source: OpenAlex

  6. Comparison of Seventh and Eighth Editions of TNM Staging Classification and Evaluation of Survivals in Operated Non-Small Cell Lung Carcinomas:Single Center Experience

    Eurasian Journal of Medical Investigation, 2020

    DOI 10.14744/ejmi.2020.81008 Source: OpenAlex

  7. Evaluation of Recent Targeted Treatments

    Güncel Göğüs Hastalıkları Serisi, 2020

    DOI 10.5152/gghs.2018.044 Source: OpenAlex

  8. The Current Strategies for Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer: The Place of Immunotherapy in Future

    Bulletin of Urooncology, 2020

    DOI 10.4274/uob.galenos.2020.1447 Open-access full textSource: OpenAlex

  9. Smokers having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment – Single-Center Experience

    Turkish Journal of Oncology, 2020

    DOI 10.5505/tjo.2020.2207 Open-access full textSource: OpenAlex

  10. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 citation (Europe PMC) Source: OpenAlex

  11. P2.06-22 Is Laboratory Prognostic Index a Valuable Prognostic Index for Malignant Pleural Mesothelioma?

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.1640 Open-access full textSource: OpenAlex

  12. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2019

    DOI 10.1007/s12094-018-1949-6 PMID 30229391 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  13. Neoadjuvant treatment in patients with locally advanced gastric cancer.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.4_suppl.127 3 citations (OpenAlex) Source: ORCID

  14. Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219890032 PMID 31793376 12 citations (OpenAlex) Source: OpenAlex

  15. A rare case of primary rectal choriocarcinoma and review of the literature

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219875510 PMID 31547751 9 citations (OpenAlex) Open-access full textSource: OpenAlex

  16. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219879757 PMID 31615346 20 citations (OpenAlex) Open-access full textSource: OpenAlex

  17. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.

    PubMed, 2019

    PMID 31646797 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  18. Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz259.007 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  19. Glioblastomda İlk Seri Sistemik Tedavi

    Turkiye Klinikleri Medical Oncology - Special Topics, 2019

    Source: OpenAlex

  20. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Open-access full textSource: OpenAlex

  21. Prognostic factors in early stage lung cancer patients: Retrospective single center data.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e20500 Source: OpenAlex

  22. P3.16-48 Is Preoperative SUV(Max) of Primary Tumor a Predictor of Relapse for Operable Non-Small Cell Lung Cancer?

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1955 Open-access full textSource: OpenAlex

  23. Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.06.014 PMID 30104029 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  24. A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy.

    Current problems in cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.04.003 PMID 29880396 12 citations (Europe PMC) Open-access full textSource: ORCID

  25. Chordoma: a case series and review of the literature

    Journal of Medical Case Reports, 2018

    DOI 10.1186/s13256-018-1784-y PMID 30145982 34 citations (OpenAlex) Open-access full textSource: OpenAlex

  26. Association of lymphadenectomy and survival in epithelial ovarian cancer

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.08.002 PMID 30149960 18 citations (OpenAlex) Open-access full textSource: OpenAlex

  27. Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.07.004 PMID 30122267 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  28. Modified Glasgow prognostic score, prognostic nutritional index and ECOG score could be new prognostic factors for survival in metastatic gastric cancer

    Annals of Oncology, 2017

    DOI 10.1093/annonc/mdx369.049 Open-access full textSource: OpenAlex

  29. Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer

    Journal of B.U.ON., 2017

    PMID 29135102 1 citation (OpenAlex) Open-access full textSource: ORCID

  30. Analysis of survival and prognostic factors in metastatic colorectal cancer patients treated with first line bevacizumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15009 1 citation (OpenAlex) Source: OpenAlex

  31. P1.03-040 Smokers Having Activating EGFR Mutant Non-Small Cell Lung Cancer Might Benefit from EGFR-TKI Treatment - Single Center Experience

    Journal of Thoracic Oncology, 2017

    DOI 10.1016/j.jtho.2017.09.844 Open-access full textSource: OpenAlex

  32. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

    Tumor Biology, 2016

    DOI 10.1007/s13277-015-4776-1 PMID 26753955 11 citations (Europe PMC) Source: OpenAlex

  33. Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer

    Oncology Research and Treatment, 2016

    DOI 10.1159/000444272 PMID 27030981 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  34. Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

    Clinical Colorectal Cancer, 2016

    DOI 10.1016/j.clcc.2016.04.013 PMID 27247089 17 citations (Europe PMC) Source: OpenAlex

  35. Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology

    Tumor Biology, 2016

    DOI 10.1007/s13277-016-5076-0 PMID 27173124 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  36. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-4359-1 PMID 26553363 13 citations (Europe PMC) Open-access full textSource: OpenAlex

  37. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy

    Clinical & Translational Oncology, 2015

    DOI 10.1007/s12094-015-1283-1 PMID 25786367 23 citations (OpenAlex) Source: OpenAlex

  38. The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

    Clinical & Translational Oncology, 2015

    DOI 10.1007/s12094-015-1408-6 PMID 26459249 3 citations (OpenAlex) Source: OpenAlex

  39. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.3_suppl.60 1 citation (OpenAlex) Source: OpenAlex

  40. Treatment and prognosis in mucosal melanoma: An Anatolian Society of Medical Oncology Study.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e20051 Source: OpenAlex